Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | LPL | P06858 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10492672 | 0.94 | CNR1 (0.38) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL19619234 | 0.89 | NPC1 (0.33) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL7737459 | 0.85 | ALDH1A1 (0.55) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL7700304 | 0.85 | CNR1 (0.46) | CNR1CNR2NPC1RAB9ACA2 | |
| SCHEMBL19251069 | 0.85 | GABRA1 (0.32) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL11616670 | 0.84 | HPGD (0.50) | NPC1MAPTRAB9ACA2ALDH1A1 | |
| SCHEMBL3790998 | 0.84 | CYP3A4 (0.50) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL18380130 | 0.84 | NPC1 (0.33) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL25707543 | 0.84 | IDO1 (0.35) | CNR1CNR2GFERNPC1MAPT | |
| SCHEMBL27715319 | 0.84 | PTGS2 (0.52) | CNR1CNR2NPC1RAB9AGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080244963-A1 | Lead-Free Aviation Fuel | TOTAL FRANCE (FR) | 2008-10-09 | — | — | US | claimed |
| EP-1971668-A1 | LEAD-FREE AVIATION FUEL | Total France (FR) | 2008-09-24 | — | — | EP | claimed |
| WO-2007074226-A1 | LEAD-FREE AVIATION FUEL | TOTAL FRANCE (FR) | 2007-07-05 | — | — | WO | claimed |
| US-20170073357-A1 | BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING | BRISTOL-MYERS SQUIBB COMPANY | 2017-03-16 | — | — | US | disclosed |
| US-20160013392-A1 | METHOD OF PRODUCING THERMOELECTRIC CONVERSION ELEMENT AND METHOD OF PREPARATION DISPERSION FOR THERMOELECTRIC CONVERSION LAYER | FUJIFILM CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-20160013392-A1 | METHOD OF PRODUCING THERMOELECTRIC CONVERSION ELEMENT AND METHOD OF PREPARATION DISPERSION FOR THERMOELECTRIC CONVERSION LAYER | FUJIFILM CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-20080244963-A1 | Lead-Free Aviation Fuel | TOTAL FRANCE (FR) | 2008-10-09 | — | — | US | disclosed |
| US-4164511-A | Manufacture of N-arylglycinonitriles | BASF AKTIENGESELLSCHAFT (DE) | 1979-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170073357-A1 | BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING | GABRA1, GABRA3, GABRA2 | CNR1 38/4885CNR2 83/4885GFER 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.